Austrianova
A cutting edge Biotech company based in Singapore embracing leading world quality standards for the production.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 Valuation: €0.0 | round | |
* | N/A | Late VC | |
| Total Funding | 000k | ||
Related Content
Austrianova specializes in cell encapsulation technology, providing innovative solutions for the protection, storage, and transport of living cells and biological molecules. Operating in the biotechnology sector, Austrianova serves pharmaceutical companies, research institutions, and biotech firms. The company's core product is its proprietary cell encapsulation technology, which allows for the free diffusion of nutrients and waste products while protecting cells from external threats. This technology is used for various applications, including immunoprotection, localization in patients, and ambient storage of probiotic bacteria and yeast. Austrianova's business model is B2B, offering a full GMP service for living eukaryotic human and animal cells, including cell banking and processing in compliance with US FDA standards. The company generates revenue through service contracts and partnerships with other biotech firms.
Keywords: cell encapsulation, biotechnology, immunoprotection, cell storage, cell transport, GMP service, eukaryotic cells, cell banking, FDA compliant, B2B.